SHOW DIRECTORY
All-In
Industry veterans Chamath Palihapitiya, Jason Calacanis, David Sacks, and David Friedberg cover economics, technology, politics, society, and poker.
SOURCE DESCRIPTION · RSS
203 EPISODESENTRACKED SHOW
SUBSCRIBE[Feed_]
Language
Inside the GLP-1 Gold Rush: Eli Lilly CEO on New Breakthroughs, Addiction & Mental Health, Pricing
Lilly’s GLP-1 franchise reflects an 18-year compounding bet, with tirzepatide reaching $8.1 billion in Q2 revenue and roughly 20 million prescription users globally as the opportunity expands beyond weight loss.Lilly cut its direct price to $499 and expects an oral drug next year, but reimbursement, patent expiry, R&D funding, biotech distress, and conditional brain-health applications remain key variables.